Replimune REPL
NASDAQ REPL
$15.03 -0.26 (-1.70%)
As of: Sep 4, 2026 · 2:31 PM EDT

Replimune (REPL) Treasury Shares (2018)

Replimune (REPL) posted Treasury Shares of $5.5 million for Q1 2026, down 2.72% sequentially from $5.7 million in Q4 2025, and up 52.53% YoY from $3.6 million in Q1 2025.

Analysis

Replimune (REPL) Treasury Shares (2018) Analysis & Trends

Replimune has reported Treasury Shares for 7 years, with the latest figure at $5.5 million in Q1 2026.

  • Quarterly Treasury Shares rose 52.53% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 52.53% YoY) and the FY2026 annual result came in at $5.5 million, up 52.53% from the prior year.
  • Treasury Shares declined to $5.5 million in Q1 2026 per REPL's latest filing, from $5.7 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $5.7 million in Q4 2025 and troughed at $826213.0 in Q1 2022.
  • A 5-year average of $3.0 million and a median of $2.4 million in 2024 frame the typical range for Treasury Shares.
  • The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 5071.91% in 2022, then soared 46.07% in 2025.
  • Over 5 years, Treasury Shares stood at $1.4 million in 2022, then surged by 50.77% to $2.0 million in 2023, then soared by 71.06% to $3.5 million in 2024, then surged by 62.2% to $5.7 million in 2025, then declined by 2.72% to $5.5 million in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods registered $5.5 million, $5.7 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - 2.72 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -
10 Replimune 1.45 Bn 1.45 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 1.93 Mn
Jun 30, 2018 1.93 Mn
Mar 31, 2018 1.93 Mn
Mar 31, 2018 1.93 Mn